(Q34220767)

31 July 2017

title

Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. (English)

1 reference

31 July 2017

0 references

0 references

Ming-Jie Li

1

1 reference

31 July 2017

Gerhard Bauer

2

1 reference

31 July 2017

Alessandro Michienzi

3

1 reference

31 July 2017

Jiing-Kuan Yee

4

1 reference

31 July 2017

Nan-Sook Lee

5

1 reference

31 July 2017

James Kim

6

1 reference

31 July 2017

Shirley Li

7

1 reference

31 July 2017

Daniela Castanotto

8

1 reference

31 July 2017

John Zaia

9

1 reference

31 July 2017

John J Rossi

10

1 reference

31 July 2017

publication date

1 August 2003

1 reference

31 July 2017

1 reference

31 July 2017

volume

8

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

196-206

1 reference

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Toward HIV eradication or remission: the tasks ahead

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Antiretroviral resistance during successful therapy of HIV type 1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Ribozymes in gene therapy of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Development of gene therapy for hematopoietic stem cells using lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Gene therapy--promise, pitfalls, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Gene therapy: hopes, hypes, and hurdles.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Downregulation of the CCR5 beta-chemokine receptor and inhibition of HIV-1 infection by stable VA1-ribozyme chimeric transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

A nucleolar TAR decoy inhibitor of HIV-1 replication.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

CCR5-delta 32 gene deletion in HIV-1 infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Spatial association of HIV-1 tat protein and the nucleolar transport protein B23 in stably transfected Jurkat T-cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

1 reference

7 January 2021

RNA interference of HIV replication

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

D-RNAi (messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Modulation of HIV-1 replication by RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

RNAi could hold promise in the treatment of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

siRNA-directed inhibition of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Expression of small, therapeutic RNAs in human cell nuclei.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Functional siRNA expression from transfected PCR products

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

A new technique for the assay of infectivity of human adenovirus 5 DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

3'-End modification of the adenoviral VA1 gene affects its expression in human cells: consequences for the design of chimeric VA1 RNA ribozymes.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Integration of murine leukemia virus DNA depends on mitosis

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Efficient transduction of human lymphocytes and CD34+ cells via human immunodeficiency virus-based gene transfer vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

HIV-1 replication cycle

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Double-stranded nef RNA interferes with human immunodeficiency virus type 1 replication

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Inhibition of gammaherpesvirus replication by RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interference

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

HIV-1 integration in the human genome favors active genes and local hotspots

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Lentiviral vector gene transfer into fetal rhesus monkeys (Macaca mulatta): lung-targeting approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems

1 reference

https://api.crossref.org/works/10.1016%2FS1525-0016%2803%2900165-5

7 January 2021

10.1016/S1525-0016(03)00165-5

Identifiers

DOI

1 reference

release_coipkn2md5hl7cnjo4dosyh5nm

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/coipkn2md5hl7cnjo4dosyh5nm

24 November 2022

mapped directly with Wikidata item

1 reference